A COMPARATIVE STUDY BETWEEN MIFEPRISTONE VS. PLACEBO AS AN UTERINE SENSITIZER FOR SECOND TRIMESTER ABORTIONS

Introduction: Mifepristone can be used prior to prostaglandins as an uterine sensitizer in second trimester abortion. This accelerates the expulsion of fetus. This study was done to compare the efficacy and side effects of using oral mifepristone tablet vs placebo 24 hours prior to induction of sec...

Full description

Bibliographic Details
Published in:	National Journal of Medical Research
Main Authors:	Meetali Parashar, Kiran Trivedi, Sashi Bala Singh, Rajesh Kumar
Format:	Article
Language:	English
Published:	Medsci Publications 2019-12-01
Subjects:	second trimester abortion mifepristone misoprostol induction delivery interval
Online Access:	http://njmr.in/index.php/file/article/view/139

Similar Items

Comparison of Two Different Intervals of Misoprostol Administration in Second Trimester Abortions
by: Anjali Gupta, et al.
Published: (2023-06-01)

Mifepristone and Misoprostol Induced Abortion with A Large Myomatous Uterus
by: Yiu-Tai Li, et al.
Published: (2005-06-01)

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
by: Tariku Shimels, et al.
Published: (2023-03-01)

Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review
by: Ferid A. Abubeker, et al.
Published: (2020-07-01)

Concurrent Use of Mifepristone and Misoprostol for Early Medical Abortion
by: Yiu-Tai Li, et al.
Published: (2006-12-01)

Use of Mifepristone and Sublingual Misoprostol for Early Medical Abortion
by: Mau Lin, et al.
Published: (2006-12-01)

A prospective study of sublingual misoprostol following mifepristone for second trimester termination of pregnancy
by: Ruchi Gupta, et al.
Published: (2019-07-01)

Comparative study of sublingual versus vaginal misoprostol following mifepristone in early first trimester medical termination of pregnancy - a prospective study
by: B. L Pathak, et al.
Published: (2019-01-01)

Monitoring Medical Abortion Using Mifepristone/Misoprostol Combination with Ultrasonogram and Serum Human Chorionic Gonadotropin
by: Szu-Yuan Chou, et al.
Published: (2006-03-01)

Simultaneous use of mifepristone and misoprostol for early pregnancy termination
by: Yiu-Tai Li, et al.
Published: (2011-03-01)

A randomized comparison of three early medical abortion regimes: Mifepristone and misoprostol, misoprostol alone and methotrexate and misoprostol
by: Renuka Brijwal, et al.
Published: (2025-07-01)

Comparison of sequential vaginal and sublingual misoprostol after a vaginal loading dose for second-trimester abortion
by: Ming-Chao Huang, et al.
Published: (2017-06-01)

Low dose Mifepristone (100 mg) for medical termination of pregnancy
by: Shikha Seth, et al.
Published: (2011-09-01)

Efficacy of Mifepristone/Misoprostol Combination for Medical Abortion Determined by Detection of Retained Products in a Community Hospital in Taipei, Taiwan
by: Szu-Yuan Chou, et al.
Published: (2004-06-01)

Comparison of the Efficacy of Vaginal Misoprostol with and without Laminaria in Second Trimester Induction Abortion
by: Z Salari, et al.
Published: (2012-02-01)

A prospective study on the effectiveness of a combination regime (Mifepristone and Misoprostol) in comparison with Misoprostol for missed abortion
by: Nidhi Gupta, et al.
Published: (2023-10-01)

Induction of abortion in the first trimester of pregnancy using letrozole and misoprostol combination versus misoprostol alone - A comparative observational study
by: Swarnali Biswas, et al.
Published: (2024-01-01)

To Study the Efficacy of Intraamniotic Prostaglandin F2 Alpha versus Mifepristone and Misoprostol Combination for Mid-trimester Medical Termination of Pregnancy
by: NM Anupam Kapur, et al.
Published: (2024-08-01)

Differences in pain, bleeding, and satisfaction during medical abortion at very early gestations
by: Frida Gyllenberg, et al.
Published: (2025-09-01)

High-Dose Misoprostol as An Alternative Therapy After Failed Medical Abortion
by: Yiu-Tai Li, et al.
Published: (2008-12-01)

Outpatient medical management of later second trimester abortion (18–23.6 weeks) with procedural evacuation backup: A large case series
by: Sruthi Chandrasekaran, et al.
Published: (2024-01-01)

Effectiveness and Safety of Medical Abortion with Mifepristone and Sublingual Misoprostol up to 63 Days of Gestation
by: Prakasit Saengbanyang, et al.
Published: (2024-09-01)

Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial)
by: Joyce van den Berg, et al.
Published: (2019-11-01)

Association of Obstetrical Variables with Induction to Expulsion Interval in Misoprostol-Induced Mid-Trimester Abortion
by: Bushra Iftikhar, et al.
Published: (2017-06-01)

Effect of mifepristone-misoprostol versus misoprostol in the management of intrauterine fetal death: A comparative study
by: T R Sindhuri, et al.
Published: (2020-01-01)

Induction of Labor Using Misoprostol With or Without Mifepristone in Intrauterine Deat
by: Ajay Agrawal, et al.
Published: (2014-06-01)

A Comparative Study of Vaginal Misoprostol and High Dose Intravenous Oxytocin for Second Trimester Pregnancy Termination
by: Minoo Rajaee, et al.
Published: (2010-06-01)

Landscape assessment of the availability of medical abortion medicines in India
by: Priya Karna, et al.
Published: (2024-06-01)

Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities
by: Amy Grossman, et al.
Published: (2023-04-01)

Medicamentous abortion with mifepristone and misoprostol in Serbia and Montenegro
by: Stojnić Jelena, et al.
Published: (2006-01-01)

Short‐term efficacy and safety of early medical abortion in Japan: A multicenter prospective study
by: Yutaka Osuga, et al.
Published: (2023-01-01)

SECOND TRIMESTER MEDICAL TERMINATION OF PREGNANCY. CHALLENGES OF IMPLEMENTATION
by: S. V. Apresyan, et al.
Published: (2017-12-01)

ALTERNATIVE APPROACHES TO MEDICAL ABORTION
by: K. Telbiyska, et al.
Published: (2024-03-01)

Partial Hydatidiform Mole in a Medical Abortion with the Mifepristone/Misoprostol Combination
by: Pui-Ki Chow, et al.
Published: (2004-12-01)

Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death
by: Damyanti Sharma, et al.
Published: (2011-09-01)

Self-managed medication abortion outcomes: results from a prospective pilot study
by: Heidi Moseson, et al.
Published: (2020-10-01)

A descriptive summary of the WHO availability assessments of medical abortion medicines in eight African countries
by: Amy Grossman, et al.
Published: (2024-12-01)

Evaluating women’s acceptability of treatment of incomplete second trimester abortion using misoprostol provided by midwives compared with physicians: a mixed methods study
by: Susan Atuhairwe, et al.
Published: (2022-11-01)

Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial
by: Charlotte Hamel, et al.
Published: (2021-02-01)

Comparison of the Effect of Letrozole and Misoprostol versus Misoprostol Alone on First Trimester Abortion
by: M Mokhtari, et al.
Published: (2023-03-01)